P
LLY icon

Palladiem’s Eli Lilly LLY Stock Holding History

Palladiem’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$394K Sell
328
-66
-17% -$67.4K 0.38% 32
2026
Q1 		$376K Buy
394
+31
+9% +$31.4K 0.36% 31
2025
Q4 		$391K Buy
+363
New +$347K 0.37% 28
2015
Q3 		$15K Hold
178
– – 0.02% 80
2015
Q2 		$15K Hold
178
– – 0.01% 108
2015
Q1 		$13K Hold
178
– – 0.01% 106
2014
Q4 		$12K Buy
+178
New +$12K 0.01% 118

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Palladiem's LLY Position: Q2 2026 in Review

Palladiem reduced its Eli Lilly (LLY) stake by 17% in Q2 2026, selling an estimated $67.4K and leaving 328 shares worth $394K. The position accounts for 0.38% of the portfolio, ranked #32.

Palladiem first reported a position in LLY in Q4 2014 and has held it in 7 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Palladiem held 328 shares of Eli Lilly worth $394K as of Q2 2026.
  • Palladiem sold 66 Eli Lilly shares in Q2 2026, an estimated $67.4K.
  • Eli Lilly made up 0.38% of Palladiem's portfolio in Q2 2026, its #32 holding.
  • Palladiem first reported a position in Eli Lilly in Q4 2014 and has held it in 7 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Palladiem's 13F filing for Q2 2026, filed 13 Aug 2026.